201 |
FARMACEUTISKA TJÄNSTERS SYNLIGHET PÅ APOTEK : Utveckling av en observationsmallDogani, Mergime January 2020 (has links)
No description available.
|
202 |
Trombolys och Antiinflammatorisk behandling vid stroke : En litteraturstudieElchoucairi, Khaled January 2020 (has links)
No description available.
|
203 |
HUR EFFEKTIV OCH SÄKER ÄR ACETYLSALICYLSYRA SOM PROFYLAX MOT PREEKLAMPSIBethouart, Sakina January 2021 (has links)
No description available.
|
204 |
COVID-19 Vaccines : A literature analysis of the three first approved COVID-19 Vaccines in the EUPersson, Morgan January 2021 (has links)
No description available.
|
205 |
Kan antivirala medel användas för behandling av covid-19?Hassan, Fadja January 2021 (has links)
No description available.
|
206 |
Hur har könsskillnader i läkemedelsanvändningen i Sverige förändrats? : En registerbaserad tvärsnittsstudieRemes, Mimmi January 2023 (has links)
Gender differences in drug use in Sweden – a systematic analysis of changes taking place during a decade Background: From a global perspective, Sweden upholds a high-quality healthcare provided on equal terms. Despite this, there are differences in health and living conditions as well as drug utilization between men and women. Aim: The aim of this study was to analyze how gender differences in drug use in Sweden have changed over the past 10 years. Specifically, to observe within which pharmacological groups large increases and decreases have taken place between 2011 and 2021. Method: A quantitative cross-sectional study was conducted to compare the prevalence of drug use between women and men in 2011 and 2021. The study used data from the Swedish Prescribed drug register containing information about all dispensed prescription drugs. Results: The gender differences differ depending on whether the differences are analyzed in relative or absolute terms. The largest sex difference in absolute numbers was antibiotics with a greater use were in women, while lipid lowering agents were showed the highest use among males. The largest increase in relative gender difference from 2011 to 2021 was for antimigrane preparations while the relative gender differences has decreased most substantially for mineral substances. Conclusion: The study shows that gender differences still exist and have not decreased in the last 10 years. Some findings on gender differences could be explained using research on prevalence of diseases between the sexes, while some differences could not be justified using medical explanations. Unexplainable gender differences can be explained by normative structures that exist and affect healthcare in Swedish society.
|
207 |
Effekt og sikkerhed af Vortioxetin på kognitiv funktion hos patienter med svær depressionEl-Kaaby, Naba January 2023 (has links)
No description available.
|
208 |
Elagolix och relugolix vid endometrios – En jämförelse av effekt och säkerhetEriksson, Elise January 2023 (has links)
No description available.
|
209 |
PÅVERKAN AV VITAMIN D PÅ DET METABOLA SYNDROMET_Kan vitamin D brist leda till ökad risk för att drabbas av det metabola syndromet?Izzat Shamoun, Yana January 2023 (has links)
No description available.
|
210 |
SGLT2-hämmare i verkliga hjärtsviktspopulationerGötesson, Ulrika January 2023 (has links)
No description available.
|
Page generated in 0.0626 seconds